Lemmen Jesse, Mageto Susan, Njuguna Festus, Midiwo Nancy, Langat Sandra, Vik Terry, Kaspers Gertjan, Mostert Saskia
Pediatric Oncology, Emma Children's Hospital, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, the Netherlands.
Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.
Afr Health Sci. 2024 Sep;24(3):230-241. doi: 10.4314/ahs.v24i3.27.
The number of children surviving cancer in low and middle-income countries is expected to grow in the coming years. Knowledge about late effects and follow-up preferences in Kenya is lacking.
This study assessed self-reported late effects in Kenyan childhood cancer survivors and explored their preferences for survivorship care.
Childhood cancer survivors, having successfully completed treatment for at least one year, were interviewed using semi-structured questionnaires during clinic or home visits between 2021-2022. Medical records were reviewed for patient and treatment characteristics.
Twenty-six survivors of hematological malignancies (n=19, 73%), solid tumors (n=6, 23%), unknown tumor type (n=1, 4%), were interviewed. Most survivors (n=19, 73%) solely received chemotherapy and one survivor (4%) was irradiated. Median time since treatment completion was seven years. Fifteen survivors (58%) were previously lost to follow-up. Many survivors (n=19; 73%) self-reported late effects, predominantly pain and fatigue. Survivors (n=11, 42%) were limited in daily life activities: physical work (n=10, 38%), personal care (n=6, 23%), social activities (n=6, 23%). Eight survivors (31%) recalled being informed about late effects. Some survivors experienced a negative attitude toward cancer in regional hospitals. Follow-up duration was longer among informed patients (p=0.043). Survivors recommended education and survivor meetings and preferred their follow-up to be done at the referral center.
Kenyan childhood cancer survivors self-report late effects, comparable in frequency, nature and severity to other survivors worldwide. Survivors and healthcare providers require education about the lifelong impact of childhood cancer and should have access to survivorship expertise to continue follow-up.
预计在未来几年,低收入和中等收入国家中癌症存活儿童的数量将会增加。肯尼亚缺乏关于癌症远期效应及随访偏好的相关知识。
本研究评估了肯尼亚儿童癌症幸存者自我报告的远期效应,并探讨了他们对癌症存活期护理的偏好。
在2021年至2022年期间,对成功完成治疗至少一年的儿童癌症幸存者进行门诊或家访,使用半结构化问卷进行访谈。查阅病历以了解患者和治疗特征。
对26名血液系统恶性肿瘤幸存者(n = 19,73%)、实体瘤幸存者(n = 6,23%)、肿瘤类型不明的幸存者(n = 1,4%)进行了访谈。大多数幸存者(n = 19,73%)仅接受了化疗,一名幸存者(4%)接受了放疗。自治疗结束后的中位时间为7年。15名幸存者(58%)此前失访。许多幸存者(n = 19;73%)自我报告有远期效应,主要是疼痛和疲劳。幸存者(n = 11,42%)在日常生活活动中受到限制:体力劳动(n = 10,38%)、个人护理(n = 6,23%)、社交活动(n = 6,23%)。8名幸存者(31%)回忆说被告知过远期效应。一些幸存者在地区医院经历了对癌症的消极态度。在被告知的患者中,随访时间更长(p = 0.043)。幸存者建议开展教育和幸存者会议,并希望在转诊中心进行随访。
肯尼亚儿童癌症幸存者自我报告的远期效应在频率、性质和严重程度上与全球其他幸存者相当。幸存者和医疗保健提供者需要接受关于儿童癌症终身影响的教育,并且应该能够获得癌症存活期护理专业知识以继续进行随访。